Masashi Nishino, Takaki Yoshikawa, Hirokazu Shoji, Yurina Fujisaki, Rei Ogawa, Takeyuki Wada, Tsutomu Hayashi, Yukinori Yamagata, Yasuyuki Seto. "SOX/FOLFOX+nivolumab followed by conversion surgery for HER2 negative primary gastric or gastroesophageal junction cancer with oligo-metastasis or borderline resectable tumors: Early results of a consecutive 41 cases.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.4_suppl.487